ClinicalTrials.gg
SupplementDrug

Lacticaseibacillus casei clinical trials

Also written Lactobacillus casei.

studies test it
6
open now
2
in phase 3
3
first study started
2006

Counted the way a researcher would: Lacticaseibacillus casei with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Lacticaseibacillus casei is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lacticaseibacillus casei studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Other names

Lactobacillus casei
3

In one entry with another drug

Given together, or one or the other

Lactobacillus acidophilus CL1285 and Lactobacillus casei
2

Studies by the year they started

6 studies that test it; most in 2006 (2)

Studies that test Lacticaseibacillus casei, by start year
YearStudies
20062
20091
20101
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 3
3
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 4

Bio-K Plus International Inc. (2) · Hospital Cristo Re (1) · Georgetown University (1) · National Institute of Pediatrics, Mexico (1) · University of Minnesota (1)

Often tested with

Tested in the same studies.

Lactobacillus acidophilus CL1285 (2) · Mesalamine (1) · Lactobacillus rhamnosus (1) · Bifidobacterium bifidum (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Lacticaseibacillus casei.

Studies

Open first, then newest update. How each study uses Lacticaseibacillus casei is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

Codes

What other systems call Lacticaseibacillus casei · ClinicalTrials.gg INT017888

  • RxNorm 1592255One source FDA
  • Wikidata Q139777Lacticaseibacillus caseiOne source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.